PetMed Express, Inc. Forecast, price target & analysts
$3.16
2.27%
Nasdaq,
Apr 21, 10:00 pm CET
PetMed Express, Inc. Target price 2025 - Analyst rating & recommendation
Powered by
PetMed Express, Inc. Classifications & Recommendation:
Hold
50%
Sell
50%
PetMed Express, Inc. Price Target
| Target Price | $3.60 |
| Price | $3.16 |
| Potential |
13.92%
register free of charge
|
| Number of Estimates | 2 |
|
2 Analysts have issued a price target PetMed Express, Inc. 2026 .
The average PetMed Express, Inc. target price is $3.60.
This is
13.92%
register free of charge
$4.00
26.58%
register free of charge
$3.20
1.27%
register free of charge
|
|
| A rating was issued by 2 analysts: 0 Analysts recommend PetMed Express, Inc. to buy, 1 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the PetMed Express, Inc. stock has an average upside potential 2026 of
13.92%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
Create a premium account to unlock analyst estimates.
Learn more
Powered by
Quarter
Annually
| Mar '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 281.06 | 231.60 |
| 9.54% | 17.60% | |
| EBITDA Margin | 0.03% | 1.75% |
| 99.19% | 5,365.06% |
2 Analysts have issued a sales forecast PetMed Express, Inc. 2025 . The average PetMed Express, Inc. sales estimate is
$232m
Unlock
6.24%
lower
Unlock
$235m
5.06%
Unlock
$229m
7.41%
Unlock
This results in the following potential growth metrics:
2 Analysts have issued an PetMed Express, Inc. EBITDA forecast 2025. The average PetMed Express, Inc. EBITDA estimate is
$4.1m
Unlock
45.50%
lower
Unlock
$4.4m
41.21%
Unlock
$3.7m
49.80%
Unlock
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Mar '24 |
2025 Estimates |
|
|---|---|---|
| EV/Sales | 0.06 |
Current PetMed Express, Inc. Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Apr 17 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Apr 17 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
